“www닷 yeotop4 。 COM 》 애오개오피✧애오개키스방➙애오개건마✸애오개OPご애오개오피Ⅱ애오개풀싸롱ょ애오개안마”的搜索结果，显示 341-350 项，共有 11054 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Effective treatments for recurrent gynecological cancer are lacking, and there is a need for novel therapeutic options. One of the barriers to improving ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Effective treatments for recurrent gynecological cancer are lacking, and there is a need for novel therapeutic options. One of the barriers to improving ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer ...

6. 神经科- 临床试验- 妙佑医疗国际

   The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

7. 针刺疗法- 妙佑医疗国际

   有些人认为这种刺激可以增强身体的天然止痛功能。 产品与服务. 书籍：《妙佑医疗国际疼痛缓解指南》 ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Frailty is thought to be mediated by senescent cells and their dynamic secretome, referred to as the senescence-associated secretory phenotype (SASP). Senescent ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Rochester, Minn. The primary objectives of this study are to determine the maximum tolerated dose/recommended phase 2 dose (MTD/RP2D) of selumetinib + ...